VANCOMYCIN, 500 mg and 1 g Vial, NOVAPLUS U.S. Physician Prescribing Information Other (vancomycin hydrochloride, USP)

Fliptop Vial

For Intravenous Use

Rx only

To reduce the development of drug-resistant bacteria and maintain the effectiveness of vancomycin hydrochloride for injection and other antibacterial drugs, vancomycin hydrochloride for injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.

POST MARKETING REPORTS

The following adverse reactions have been identified during post-approval use of vancomycin. Because these reactions are reported voluntarily from a population of uncertain size, it is not possible to reliably estimate their frequency or establish a causal relationship to drug exposure.

 
Skin and Subcutaneous Tissue Disorders
 
Drug Rash with Eosinophilia and Systemic Symptoms (DRESS)

To report SUSPECTED ADVERSE EVENTS, contact FDA at 1-800-FDA-1088 or www.fda.gov.

Distributed by Hospira, Inc., Lake Forest, IL 60045 USA

Logo

Novaplus is a registered trademark of Vizient, Inc.

LAB-1035-8.0
Revised: 08/2020

Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No